ECL Detection Reagents from GE Healthcare, formerly Amersham Biosciences

Description

Amersham ECL Direct™ Nucleic Acid Labeling and Detection System
  • For fast and easy detection of medium- to high-target amounts in applications such as colony/plaque screens, dot blots and PCR product analyses.
  • Consistent results combining strong signals with very low backgrounds.
  • No need to strip the blot before reprobing: saves time, reduces membrane damage and minimizes exposure to hazardous chemicals.
  • Less than 4 h from probe labeling to detection in high-target amount applications with no antibody steps.
GE Healthcare, formerly Amersham Biosciences
GE Healthcare, formerly Amersham Biosciences
US and Canada 800 Centennial Avenue PO Box 1327
Piscataway, New Jersey
United States
Phone: 1-800-526-3593
732-235-2201
Company Profile
Website: http://www.gelifesciences.com